Financials

News Discussions Technicals Seasonals

Gross profit of ABVC BioPharma, Inc.

Annual data

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

TTM

‪‪−250.00 K‬‬

‪0.00‬

‪‪250.00 K‬‬

‪‪500.00 K‬‬

‪‪750.00 K‬‬

Period

Value

Change

Change %

TTM

‪‪340.63 K‬‬

+‪‪518.77 K‬‬

—

2023

‪‪−178.14 K‬‬

‪‪−837.71 K‬‬

‪−127.01‬%

2022

‪‪659.57 K‬‬

+‪‪320.85 K‬‬

+‪94.73‬%

2021

‪‪338.72 K‬‬

‪‪−88.47 K‬‬

‪−20.71‬%

2020

‪‪427.19 K‬‬

‪‪−199.31 K‬‬

‪−31.81‬%

2019

‪‪626.50 K‬‬

+‪‪848.43 K‬‬

—

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

Quarterly data

Q4 '16

Q1 '17

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−150.00 K‬‬

‪0.00‬

‪‪150.00 K‬‬

‪‪300.00 K‬‬

‪‪450.00 K‬‬

Period

Value

Change

Change %

Q3 '24

‪‪381.97 K‬‬

+‪‪278.32 K‬‬

+‪268.53‬%

Q2 '24

‪‪103.65 K‬‬

+‪‪104.00 K‬‬

—

Q1 '24

‪−358.00‬

+‪‪144.26 K‬‬

+‪99.75‬%

Q4 '23

‪‪−144.62 K‬‬

‪‪−123.43 K‬‬

‪−582.54‬%

Q3 '23

‪‪−21.19 K‬‬

+‪‪45.68 K‬‬

+‪68.31‬%

Q2 '23

‪‪−66.87 K‬‬

‪‪−128.41 K‬‬

‪−208.66‬%

Q1 '23

‪‪61.54 K‬‬

‪‪−255.60 K‬‬

‪−80.59‬%

Q4 '22

‪‪317.15 K‬‬

+‪‪292.08 K‬‬

+‪‪1.17 K‬‬%

Q3 '22

Q2 '22

Q1 '22

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19

Q1 '19

Q4 '18

Q3 '18

Q2 '18

Q1 '18

Q4 '17

Q3 '17

Q2 '17

Q1 '17

Q4 '16